These Giants Have Been Dormant, Now They Surprise Investors
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
When To Start Financial Planning For Retirement
Starting financial planning for retirement is crucial for a secure future. Learn the best time to begin and set your goals effectively.
20,569 articlesRare Stock Market Signal Flashes for 9th Time Since 1950
A rare stock market signal has flashed again, marking the ninth occurrence since 1950. Goldman Sachs says the readout...
CFPB Prioritizes Streamline Refis, GSE Pathway Looms
Regulators signal a push on Regulation X changes and a new GSE streamline refi pathway, as LO Comp revisions lose mom...
House Points Fingers as Smithsonian Women’s Museum Funding Fails
The House rejected a bill to fund the Smithsonian American Women’s History Museum, triggering a partisan clash that l...
Elon Musk’s SpaceX Filing Flags AI Bet Beyond Rockets
SpaceX’s IPO filing reveals a company pivoting from rockets to AI infrastructure, with heavy spending and a long road...
BitMine’s $126M Ethereum Sets Stage for Russell Test
BitMine expands its Ethereum hoard to 60,000 ETH worth about $126 million as it enters the Russell 1000 preliminary l...
Bitcoin Eyes $80K Rally as Peace Talks Promise Relief
Bitcoin moved back toward the $80,000 mark as global markets priced in a potential de-escalation in Middle East tensi...
Altman CHATGPT Predicts Price: XRP Set for June Breakout
A prompt-driven AI model inspired by Altman and CHATGPT outlines a potential XRP breakout by the end of June 2026. Th...
Magnificent Seven Done Reporting: Top 3 Buys Now
The quarter is over and the magnificent seven done reporting. Here are three buys that stand out for ambitious invest...
Short Sellers Betting Record as Stocks Rally on Iran Talks
Equities cling to gains near all-time highs as hedge funds maintain elevated short positions. A possible Iran deal fu...
Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Time To Notice Score Change After Secured Card
Secured Card Reported To Credit Bureaus Instantly